Enhanced Endothelium-Dependent Vasodilation in Fabry Disease
Open Access
- 1 July 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (7) , 1559-1562
- https://doi.org/10.1161/01.str.32.7.1559
Abstract
Background and Purpose —Fabry disease is an X-linked lysosomal storage disease secondary to deficiency of α-galactosidase A with resulting glycolipid accumulation, particularly globotriaosylceramide in arterial smooth muscle and endothelial cells. A systemic vasculopathy, including early-onset stroke, is prevalent without a clear pathogenesis. Methods —Seventeen normotensive and normocholesterolemic hemizygous Fabry patients (aged 21 to 49 years) and 13 control subjects (aged 21 to 48 years) were investigated by venous plethysmography, allowing assessment of forearm blood flow. Plethysmographic measurements were obtained at baseline and during intra-arterial infusion of acetylcholine and sodium nitroprusside both with and without N G -monomethyl- l -arginine (L-NMMA). Results —Forearm blood flow was significantly higher in patients than in control subjects at all 3 acetylcholine doses ( P =0.014). Patients had a greater response to acetylcholine even after the addition of L-NMMA ( P =0.036). Conclusions —These results demonstrate an increased endothelium-mediated vascular reactivity in Fabry disease. The increased vessel response to acetylcholine with and without L-NMMA suggests altered functionality of non-NO endothelium-dependent vasodilatory pathways.Keywords
This publication has 18 references indexed in Scilit:
- Double-Blind, Randomized, Controlled Trial of Albuterol in Facioscapulohumeral DystrophyNeurology, 2000
- Cerebrovascular complications of Fabry's diseaseAnnals of Neurology, 1996
- Regulatory Functions of the Vascular EndotheliumNew England Journal of Medicine, 1990
- Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential HypertensionNew England Journal of Medicine, 1990
- A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxationBritish Journal of Pharmacology, 1989
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.Proceedings of the National Academy of Sciences, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive manActa Physiologica Scandinavica, 1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980